Eligible women ( @-@ years ) , with World Health Organization Group II anovulatory infertility , were randomized to receive r-hFSH ( starting daily dose : @ IU ) as a chronic low-dose ( CLD ) ( @ IU dose increase on Day @ ) or low-dose ( LD ) ( @ IU dose increase on Day @ ) protocol if no follicles were @ mm .